New hope for Tough-to-Treat breast cancer patients in china
NCT ID NCT04454437
Summary
This study is testing how well a drug called sacituzumab govitecan works for Chinese patients with advanced triple-negative breast cancer that has continued to grow despite at least two prior chemotherapy treatments. The main goal is to see how many patients' tumors shrink in response to the drug. The study will also track how long the benefit lasts and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Hospital
Hefei, 230001, China
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Chinese PLA General Hospital
Beijing, 100853, China
-
Chongqing University Cancer Hospital
Chongqing, 404100, China
-
Hubei Cancer Hospital
Wuhan, 430000, China
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
-
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China
-
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, 510120, China
-
Sun Yat-sen University, Cancer Center
Guangzhou, 510000, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, 230022, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, 710061, China
-
The First Hospital of China Medical University
Shenyang, 110001, China
-
The First Hospital of Jilin University
Changchun, 130021, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, 300060, China
-
West China Hospital, Sichuan University
Chengdu, China
-
Zhejiang Cancer Hospital
Hangzhou, 310022, China
Conditions
Explore the condition pages connected to this study.